HomeNewsBusinessCompaniesCOVID-19: CT value can tell your viral load, but it has many limitations

COVID-19: CT value can tell your viral load, but it has many limitations

Many labs are now providing the CT value of patients who have tested positive for COVID-19. If the CT value is greater than 34, the person may not be infectious. However, as a Mumbai doctor says, it is not reliable as the CT value varies from test kit to test kit.

September 16, 2020 / 14:56 IST
Story continues below Advertisement


Mumbai-based diagnostic laboratory, iGenetic Diagnostics, began providing Cycle Threshold (CT) value on Reverse Transcription–Polymerase Chain Reaction (RT-PCR) test reports of patients who tested positive for COVID-19.

Real time RT–PCR is a nuclear-derived method for detecting the presence of specific genetic material in any pathogen, including a virus.

Story continues below Advertisement

“CT value may not be clinically significant, but we are providing it following demand from doctors and patients,” says Arunima Patel, Founder and MD, iGenetic Diagnostics.

Patel says that they give a disclaimer in the test report, clearly mentioning the limits of the CT value.

COVID-19 Vaccine
Frequently Asked Questions

View more

How does a vaccine work?

A vaccine works by mimicking a natural infection. A vaccine not only induces immune response to protect people from any future COVID-19 infection, but also helps quickly build herd immunity to put an end to the pandemic. Herd immunity occurs when a sufficient percentage of a population becomes immune to a disease, making the spread of disease from person to person unlikely. The good news is that SARS-CoV-2 virus has been fairly stable, which increases the viability of a vaccine.

How many types of vaccines are there?

There are broadly four types of vaccine — one, a vaccine based on the whole virus (this could be either inactivated, or an attenuated [weakened] virus vaccine); two, a non-replicating viral vector vaccine that uses a benign virus as vector that carries the antigen of SARS-CoV; three, nucleic-acid vaccines that have genetic material like DNA and RNA of antigens like spike protein given to a person, helping human cells decode genetic material and produce the vaccine; and four, protein subunit vaccine wherein the recombinant proteins of SARS-COV-2 along with an adjuvant (booster) is given as a vaccine.

What does it take to develop a vaccine of this kind?

Vaccine development is a long, complex process. Unlike drugs that are given to people with a diseased, vaccines are given to healthy people and also vulnerable sections such as children, pregnant women and the elderly. So rigorous tests are compulsory. History says that the fastest time it took to develop a vaccine is five years, but it usually takes double or sometimes triple that time.
View more
+ Show